FDA rejects Heron's non-opioid painkiller

06:10 EDT 2 May 2019 | pharmaphorum

Shares in US biotech Heron Therapeutics were sharply down yesterday after the FDA rejected its post-operative painkiller, saying additional manufacturing and non-clinical information is needed to approve it. In a statement the San Diego biotech sa...

Original Article: FDA rejects Heron's non-opioid painkiller


More From BioPortfolio on "FDA rejects Heron's non-opioid painkiller"

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...